| Effect of nebulised salbutamol on maximal exercise performance in men with mild asthma. | |
| | |
MedLine Citation:
|
PMID: 2595636 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The effect of 5 mg nebulised salbutamol on the cardiorespiratory responses to a progressive maximal exercise test was investigated in eight asthmatic (mean forced expiratory volume in one second (FEV1) 3.48 (1.0) litres) and eight non-asthmatic men. Exercise tests were performed on a bicycle ergometer after administration of nebulised salbutamol or matched saline placebo. In the asthmatic subjects salbutamol increased the resting FEV1 by 11%. The mean (SD) percentage fall in FEV1 after exercise did not change significantly (salbutamol 9.4 (12.8); placebo 15.0 (8.0], but because the FEV1 before exercise was increased the lowest FEV1 after exercise was also significantly higher after salbutamol than placebo (3.60 (1.13) v 2.85 (0.80) litres). Despite the improvement in FEV1 before exercise there was no significant difference in maximal workload, oxygen uptake, heart rate, or ventilation during exercise after salbutamol compared with placebo in the asthmatic patients. Tidal volume was higher at maximal exercise after salbutamol but there was no change in perception of breathlessness or exertion in the asthmatic subjects. During submaximal progressive exercise the perceived rate of exertion was reduced in the asthmatic patients and oxygen pulse was reduced in both groups owing to a small and non-significant increase in heart rate. The FEV1 and cardiorespiratory response to the progressive maximal exercise test in the non-asthmatic subjects were otherwise unchanged after salbutamol. The results suggest that 5 mg nebulised salbutamol has little effect on the cardiorespiratory responses to progressive maximal exercise in patients with mild asthma and in non-asthmatic subjects. Salbutamol in this dose may reduce the severity of exercise induced asthma, but no ergogenic effect on maximal exercise performance was shown. |
| | |
Authors:
|
W Freeman; G E Packe; R M Cayton |
Related Documents
:
|
21286106 - Exercise and the asymptomatic individual: assessment and advice. 2767426 - Exercise-induced asthma: a difference in opinion regarding the stimulus. 7938796 - Bronchial responsiveness is not always increased after allergen challenge. 22107086 - Expression of extracellular matrix components and related growth factors in human tendo... 3519236 - Efficacy of and adverse effects of disopyramide. comparison of capsules, controlled rel... 3189166 - Heart rate adjustment of st-segment depression for reduction of false positive electroc... |
Publication Detail:
|
Type: Clinical Trial; Controlled Clinical Trial; Journal Article |
Journal Detail:
|
Title: Thorax Volume: 44 ISSN: 0040-6376 ISO Abbreviation: Thorax Publication Date: 1989 Nov |
Date Detail:
|
Created Date: 1990-01-25 Completed Date: 1990-01-25 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 0417353 Medline TA: Thorax Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 942-7 Citation Subset: IM |
Affiliation:
|
Department of Respiratory Physiology, East Birmingham Hospital. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Albuterol / therapeutic use* Asthma / drug therapy*, physiopathology Exercise Test / drug effects Forced Expiratory Volume Heart Rate / drug effects Humans Male Nebulizers and Vaporizers Oxygen Consumption / drug effects |
| Chemical | |
Reg. No./Substance:
|
18559-94-9/Albuterol |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Nutritional state and exercise performance in patients with chronic obstructive lung disease.
Next Document: Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled study.